Search research articles
Contact Us
Filters
Showing results (181-190 of 255) with videos related to
Page
of 26
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 1, 1986
Long-term effects on the immune system following local radiation therapy for breast cancer. 4. Proliferative responses and induction of suppressor activity of the blood lymphocyte population
S Rotstein, H Blomgren, B Petrini, et al.
Journal of Surgical Oncology
|
September 1, 1986
Enteral and parenteral nutrition in anorectic patients with advanced gastrointestinal cancer
A Lindh, B Cedermark, H Blomgren, et al.
Advances in Immunity and Cancer Therapy
|
January 1, 1985
Cells responsible for tumor surveillance in man: effects of radiotherapy, chemotherapy, and biologic response modifiers
P Reizenstein, C Ogier, H Blomgren, et al.
Clinical Oncology
|
December 1, 1983
Distribution of lymphocyte subsets following radiation therapy directed to different body regions
H Blomgren, F Edsmyr, I Näslund, et al.
Acta Endocrinologica
|
February 1, 1991
Blood lymphocyte population following 131I treatment for hyperthyroidism
H Blomgren, J Wasserman, B Petrini, et al.
Lancet (London, England)
|
March 15, 1980
Radiotherapy, immunoreactivity, and recurrence of breast cancer
B Petrini, J Wasserman, E Baral, et al.
Oncology Reports
|
May 25, 2011
Does informed adjuvant placebo chemotherapy for breast-cancer elicit immune changes
M Lekander, C Furst, S Rotstein, et al.
Brain, Behavior, and Immunity
|
March 1, 1993
Trait anxiety and anticipatory immune reactions in women receiving adjuvant chemotherapy for breast cancer
M Fredrikson, C J Fürst, M Lekander, et al.
Anticancer Research
|
November 1, 1990
Changes of CD2 receptor density determined by electron microscopy on blood lymphocytes following radiation treatment for breast cancer
B Petrini, K O Hedlund, J Wasserman, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1987
Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder. Clinical results of a randomized trial
H Blomgren, I Näslund, P L Esposti, et al.
Page
of 26
Search research articles
Search
Showing results (181-190 of 255) with videos related to
Sort By:
Page
of 26
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
July 1, 1986
Long-term effects on the immune system following local radiation therapy for breast cancer. 4. Proliferative responses and induction of suppressor activity of the blood lymphocyte population
S Rotstein, H Blomgren, B Petrini, et al.
Journal of Surgical Oncology
|
September 1, 1986
Enteral and parenteral nutrition in anorectic patients with advanced gastrointestinal cancer
A Lindh, B Cedermark, H Blomgren, et al.
Advances in Immunity and Cancer Therapy
|
January 1, 1985
Cells responsible for tumor surveillance in man: effects of radiotherapy, chemotherapy, and biologic response modifiers
P Reizenstein, C Ogier, H Blomgren, et al.
Clinical Oncology
|
December 1, 1983
Distribution of lymphocyte subsets following radiation therapy directed to different body regions
H Blomgren, F Edsmyr, I Näslund, et al.
Acta Endocrinologica
|
February 1, 1991
Blood lymphocyte population following 131I treatment for hyperthyroidism
H Blomgren, J Wasserman, B Petrini, et al.
Lancet (London, England)
|
March 15, 1980
Radiotherapy, immunoreactivity, and recurrence of breast cancer
B Petrini, J Wasserman, E Baral, et al.
Oncology Reports
|
May 25, 2011
Does informed adjuvant placebo chemotherapy for breast-cancer elicit immune changes
M Lekander, C Furst, S Rotstein, et al.
Brain, Behavior, and Immunity
|
March 1, 1993
Trait anxiety and anticipatory immune reactions in women receiving adjuvant chemotherapy for breast cancer
M Fredrikson, C J Fürst, M Lekander, et al.
Anticancer Research
|
November 1, 1990
Changes of CD2 receptor density determined by electron microscopy on blood lymphocytes following radiation treatment for breast cancer
B Petrini, K O Hedlund, J Wasserman, et al.
Cancer Immunology, Immunotherapy : CII
|
January 1, 1987
Adjuvant Bestatin immunotherapy in patients with transitional cell carcinoma of the bladder. Clinical results of a randomized trial
H Blomgren, I Näslund, P L Esposti, et al.
Page
of 26